| ²é¿´: 457 | »Ø¸´: 1 | |||
liuzijian½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Ò©»¯×¨Àû ÕªÒª·Òë ººÒëÓ¢ ¼±
|
|
·¢Ã÷Ãû³Æ£ºÐµÄàßøÀ໯ºÏÎï¼°ÆäÓÃ; ·¢Ã÷ÊéÕªÒª ±¾·¢Ã÷Éæ¼°Í¨Ê½¢ñËùʾµÄàßøÀàÑÜÉúÎïÓëÆä¼¸ºÎÒì¹¹Ìå¼°ËüÃÇҩѧÉϿɽÓÊܵÄÑΡ¢Ë®ºÏÎï»òǰҩ£¬ÆäÖÐÈ¡´ú»ùM¡¢R1¡¢R2¡¢X¡¢Y¾ßÓÐÔÚ˵Ã÷ÊéÖиø³öµÄº¬Òå¡£±¾·¢Ã÷»¹É漰ͨʽ¢ñµÄ»¯ºÏÎï¾ßÓÐÇ¿µÄÒÖÖÆc-Met¼¤Ã¸µÄ×÷Ó㬲¢ÇÒ»¹Éæ¼°¸ÃÀ໯ºÏÎï¼°ÆäҩѧÉϿɽÓÊܵÄÑΡ¢Ë®ºÏÎïÔÚÖÆ±¸ÖÎÁÆÓÉÓÚc-Met¼¤Ã¸Òì³£¸ß±í´ïËùÒýÆð¼²²¡µÄÒ©ÎïÖеÄÓÃ;£¬ÌرðÊÇÔÚÖÆ±¸ÖÎÁƺÍ/»òÔ¤·À°©Ö¢µÄÒ©ÎïÖеÄÓÃ;¡£ |
» ²ÂÄãϲ»¶
Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö
ÒѾÓÐ16È˻ظ´
278Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏר˶µ÷¼Á
ÒѾÓÐ7È˻ظ´
304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£©
ÒѾÓÐ24È˻ظ´
»¯¹¤Ñ§Ë¶ 285Çóµ÷¼Á
ÒѾÓÐ21È˻ظ´
259Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
275 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
287Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
liuzijian
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2255
- É¢½ð: 33
- ºì»¨: 2
- Ìû×Ó: 473
- ÔÚÏß: 116.8Сʱ
- ³æºÅ: 1143493
- ×¢²á: 2010-11-10
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
|
Title£ºQuinoline derivatives and uses thereof Abstract The present invention relates to quinoline derivatives of formula I, optical isomers, pharmaceutically acceptable salts, hydrates and/or prodrug thereof. Wherein: substituents M, R1, R2, X, and Y are as defined in the description. The present invention also relates to compounds of formula I, their pharmaceutically acceptable salts and/or hydrates, which have potent inhibitory effect of c-Met kinase, can be used in preparation for treating the abnormal c-Met kinase overexpression-related diseases, especially for preparation of treatment and/or prevention of cancer. |
2Â¥2013-08-28 10:29:54














»Ø¸´´ËÂ¥